OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study (vol 49, pg 540, 2022)

被引:0
作者
Boudreau, Guy [1 ]
Finkelstein, Ian [2 ]
Graboski, Corrie [3 ]
Ong, May [4 ]
Christie, Suzanne [5 ]
Sommer, Katherine [6 ]
Bhogal, Meetu [7 ]
Davidovic, Goran [7 ]
Becker, Werner J. [8 ]
机构
[1] Ctr Hosp Univ Montreal CHUM, Montreal, PQ, Canada
[2] Toronto Headache & Pain Clin, Toronto, ON, Canada
[3] Isl Hlth, Brentwood Bay, BC, Canada
[4] St Paul Hosp, Vancouver, BC, Canada
[5] Univ Ottawa, Neurol, Ottawa, ON, Canada
[6] AbbVie Inc, Marlow, Bucks, England
[7] AbbVie Inc, Markham, ON, Canada
[8] Univ Calgary, Dept Clin Sci, Calgary, AB, Canada
关键词
D O I
10.1017/cjn.2023.317
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:149 / 149
页数:1
相关论文
共 1 条
  • [1] OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study
    Boudreau, Guy
    Finkelstein, Ian
    Graboski, Corrie
    Ong, May
    Christie, Suzanne
    Sommer, Katherine
    Bhogal, Meetu
    Davidovic, Goran
    Becker, Werner J.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2022, 49 (04) : 540 - 552